Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange. | J Transl Autoimmun | 2026 | 41782636 | PubTator, text mining | PubMed |
| Pre-existing activation states shape functional heterogeneity of human Vγ9Vδ2 T cells. | Front Immunol | 2026 | 41777882 | PubTator, text mining | PubMed |
| Proximity extension assay-based targeted proteomics for biomarker discovery in adult bacterial infections. | Front Cell Infect Microbiol | 2026 | 41769342 | PubTator, text mining | PubMed |
| Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. | Research (Wash D C) | 2026 | 41756725 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds in Inflammation-Related Cancers: Mechanisms and Therapeutic Potential. | Plants (Basel) | 2026 | 41754282 | PubTator, text mining | PubMed |
| Rational Design of Immune Gene Therapy Combinations via In Vivo CRISPR Activation Screen of Tumor Microenvironment Modulators. | Cancer Discov | 2026 | 41747251 | PubTator, text mining | PubMed |
| ACLY blockade rewires tumor metabolism to boost immunity in MASH-driven hepatic cell carcinoma. | J Natl Cancer Cent | 2026 | 41738038 | PubTator, text mining | PubMed |
| Clinical significance and oncogenic role of ECHDC2 in glioblastoma: a comprehensive analysis based on bioinformatics and in vitro experiments. | Front Genet | 2026 | 41732157 | PubTator, text mining | PubMed |
| ClusterChirp: A GPU-accelerated Web Server for Natural Language-Guided Interactive Visualization and Analysis of Large Omics Data. | ArXiv | 2026 | 41727916 | PubTator, text mining | PubMed |
| Comprehensive analysis of mitochondrial unfolded protein response related genes for prognosis and therapeutic response in pancreatic cancer. | Front Immunol | 2026 | 41727504 | PubTator, text mining | PubMed |
| Assessing Targeted Proteomics in Inflammatory Skin Diseases with the Tape-stripping Method. | Acta Derm Venereol | 2026 | 41725456 | PubTator, text mining | PubMed |
| Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy. | Front Oncol | 2026 | 41717407 | PubTator, text mining | PubMed |
| Engineered mesenchymal stem cells expressing CXCR4 and LIGHT enhance Anti-Tumor activity in a subcutaneous gastric cancer xenograft model. | Med Oncol | 2026 | 41712131 | PubTator, text mining | PubMed |
| A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis. | PLoS One | 2026 | 41650163 | PubTator, text mining | PubMed |
| Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. | J Immunother Cancer | 2026 | 41617396 | PubTator, text mining | PubMed |
| Prevalence and mechanisms of high-level carbapenem antibiotic tolerance in clinical isolates of Klebsiella pneumoniae. | PLoS Pathog | 2026 | 41616033 | PubTator, text mining | PubMed |
| Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging. | Alzheimers Dement | 2026 | 41612914 | PubTator, text mining | PubMed |
| Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants. | Sci Adv | 2026 | 41576166 | PubTator, text mining | PubMed |
| Neutrophil Extracellular Trap Components Are Present in the Aqueous Humor of Glaucoma Patients. | Transl Vis Sci Technol | 2026 | 41575444 | PubTator, text mining | PubMed |
| T-cell exhaustion indicator characterizes the tumor microenvironment landscape and predicts colon adenocarcinoma prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing. | BMC Cancer | 2026 | 41530714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=3